Onychomycosis therapy: Past, present, future

Journal of Drugs in Dermatology

Volumn 9, Issue 9, 2010, Pages 1109-1113

  Gupta, Aditya K ^a,b   Uro, Michael ^c   Cooper, Elizabeth A ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c Foot Doctor Laser Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 1,3 DIHYDRO 2,1 BENZOXABOROL 1 OL; AMOROLFINE; ANTIFUNGAL AGENT; CARBOFUCHSIN PAINT; CICLOPIROX; CISAPRIDE; DOFETILIDE; FLUCONAZOLE; FORMALDEHYDE; GRISEOFULVIN; IMIDAZOLE; ITRACONAZOLE; KERATIN; KETOCONAZOLE; LEVACETYLMETHADOL; PERMANGANATE POTASSIUM; PIMOZIDE; QUINIDINE; TERBINAFINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

APPLICATION SITE DISCOMFORT; APPLICATION SITE IRRITATION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; DERMATOPHYTE; DISINFECTION; DRUG ABSORPTION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; FINGERNAIL ONYCHOMYCOSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; INFRARED RADIATION; IONTOPHORESIS; LASER; LIVER FUNCTION TEST; LIVER TOXICITY; NAIL; NEODYMIUM LASER; NONHUMAN; PATIENT COMPLIANCE; PATIENT SAFETY; PHOTODYNAMIC THERAPY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; TASTE DISORDER; TOENAIL ONYCHOMYCOSIS; TRICHOPHYTON RUBRUM; UNSPECIFIED SIDE EFFECT; VISUAL DISORDER; HISTORY; MICROBIOLOGY; ONYCHOMYCOSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT;

ANTIFUNGAL AGENTS; HISTORY, 20TH CENTURY; HUMANS; ONYCHOMYCOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 77957961433     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Stokes JH. 1938 letter. IJD. 1999;38:827,829,840.
2. Gupta AK, Ryder JE. The use of oral antifungal agents to treat onychomycosis. Dermatol Clin. 2003;21:469-479. (Pubitemid 37022670)
3. Sporanox® (Itraconazole) capsules. Prescribing Information. Pri-Cara, Division of Ortho-McNeil-Janssen Pharmaceuticals Inc. Raritan, NJ. March 2009.
4. Gupta AK, Lambert J, Revuz J, Shear N. Update on the safety of itraconazole pulse therapy in onychomycosis and dermatomycoses. Eur J Dermatol. 2001;11(1):6-10. (Pubitemid 32150371)
5. Gupta AK, Cooper EA, Ryder JE, et al. Optimal management of fungal infections of the skin, hair, and nails. Am J Clin Dermatol. 2004;5:225-237. (Pubitemid 39127966)
6. Lamisil® (terbinafine hydrochloride tablets) Prescribing Information. Novartis Pharmaceuticals Corporation. East Hanover, NJ. November 2005.
7. Gupta AK, Ryder JE, Lynch LE, Tavakkol A. The use of terbinafine in the treatment of onychomycosis in adults and special populations: A review of the evidence. J Drugs Dermatol. 2005;4:302-308.
8. Penlac® Nail Lacquer (ciclopirox) Topical Solution, 8% Prescribing Information. Dermik Laboratories (a division of sanofi-aventis). Bridgewater, NJ. July 2006.
9. Baran R, Kaoukhov A. Topical antigungal drugs for the treatment of onlychomycosis: An overview of current strategies for monotherapy and combination therapy. J Eur Acad Derm Venerol. 2005;19:21-29. (Pubitemid 40268136)
10. Borelli C, Schaller M, Niewerth M, et al. Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy. 2008;54:245-259.
11. Hui X, Baker SJ, Wester RC, et al. In vitro penetration of a novel oxaborale antifungal (AN2690) into the human nail plate. J Pharm Sci. 2007;96(10):2622-2631. (Pubitemid 47597813)
12. Rock FL, Mao W, Yaremchuk A, et al. An antifungal agent inhibits an aminoacyl tRNA synthetase by trapping tRNA in the editing site. Science. 2007;316:1759-1761. (Pubitemid 46988553)
13. Alley MRK, Baker SJ, Beutner KR, Plattner J. Recent progress on the topical therapy of onychomycosis. Expert Opin Investig Drugs. 2007;16:157-167. (Pubitemid 46206630)
14. Amichai B, Nitzan B, Mosckovitz R, Shemer A. Iontophoretic delivery of terbinafi ne in onychomycosis: A preliminary study. Br J Dermatol. 2010;162:46-50.
15. Bornstein E. A review of current research in light-based technologies for treatment of podiatric infectious disease states. J Am Podiatr Med Assoc. 2009;99(4):348-352.
16. Manevitch Z, Lev D, Palhan M, et al. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol. 2010;86:476-479.
17. Bornstein E, Hermans W, Gridley S, Manni J. Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem Photobiol. 2009;85:1364-1374.
18. Harris DM, McDowell BA, Strisower J. Laser treatment for toenail fungus. SPIE Proceedings. 2009;7161:71610M.